Pseudomonas aeruginosa

Overview

Pseudomonas aeruginosa is the most clinically significant species within the diverse Pseudomonas genus, known for being Glyoxalase I (Glo-I) and oxidase-positive. It is a versatile Gram-negative bacterium and a major opportunistic pathogen, frequently causing hospital-acquired infections such as pneumonia and bacteremia, particularly in immunocompromised individuals. Its pathogenicity is driven by a wide array of virulence factors that enable it to colonize host tissues, evade the immune system, and cause damage, including severe wounds and tissue necrosis. P. aeruginosa is highly adaptable, rapidly acquiring antibiotic resistance and adjusting to environmental changes, further complicating treatment efforts and enhancing its ability to cause persistent infections. These virulence factors play critical roles in manipulating the host’s cellular machinery, allowing the bacterium to evade immune responses and cause significant tissue damage and dysfunction.

Associated Conditions

Virulence Factors

This table identifies the diverse mechanisms by which P. aeruginosa exerts its pathogenic effects, ranging from structural components that facilitate adhesion and biofilm formation, to secreted enzymes and toxins that directly damage host tissues and evade immune defenses. Understanding these virulence factors is critical for developing targeted interventions to treat and prevent infections caused by this adaptable and often resistant pathogen.

What are P. aeruginosa’s virulence factors?

Virulence Factor Category	Function/Role
Lipopolysaccharides (LPS)	Endotoxin: Integral to the outer membrane; varies in composition, contributing to immune evasion and systemic inflammation. [x]
Adhesins	Surface structures: Includes flagella, pili, and biofilms, facilitating colonization, biofilm formation, and evasion of immune responses. [x]
Alginate	Exopolysaccharide: Enhances biofilm viscosity and resistance, protects against phagocytosis, scavenges reactive oxygen species, and binds aminoglycosides. [x]
Flagella	Motility structure: Aids in bacterial adhesion and motility; triggers host inflammatory response via TLR5. [x]
Lectins (LecA and LecB)	Adhesion molecules: Bind to specific host cell sugars, facilitating biofilm formation and bacterial adhesion. [x]
Type IV Pili (TFP)	Adhesion filament: Involved in bacterial movement and adhesion, crucial for colonization and biofilm formation. [x, x]
Pigments	Metabolic products: Include pyoverdine, pyocyanin, pyorubin, pyomelanin, and phenazines; involved in iron acquisition, antibacterial activity, and defense against oxidative stress. [x][x][x][x][x][x]
Toxins	Secreted toxins: Exotoxin A [x] [x] and Exotoxin S [x][x] disrupt host cellular processes and immune responses, contributing to cell death and immune evasion.
Leukocidin (Cytotoxin)	Pore-forming toxin: Causes cell death in leukocytes, enhancing bacterial virulence. [x]
Enterotoxin	Secreted toxin: Induces fluid accumulation in tissues, differing from other bacterial toxins. [x]
Enzymes	Destructive enzymes: Include phospholipase C, [x] [x] [x] rhamnolipids, [x][x][x] LasB protease, [x][x] LasA protease, [x] [x] [x], and alkaline protease; [x][x][x] disrupt host cell membranes, degrade immune components, interfere with tight junctions, and facilitate tissue damage.
Metallothioneins	Metal-binding proteins: Involved in metal ion homeostasis, defense against oxidative stress, and modulation of immune responses; essential for zinc acquisition and virulence. [x][x][x]

Heavy metals and minerals

Pseudomonas aeruginosa has a multifaceted relationship with heavy metals that significantly influences its adaptability, survival, pathogenicity, and antibiotic resistance. This bacterium thrives in environments with heavy metal contamination, employing mechanisms such as efflux pumps, metal-binding proteins, enzymatic detoxification, and biofilm formation to resist toxic levels of metals like lead, mercury, copper, zinc, cadmium, and nickel. Iron, zinc, magnesium, and calcium are essential for its biofilm stability and virulence, while exposure to heavy metals can enhance its virulence factors. Furthermore, heavy metal resistance is closely linked to antibiotic resistance in P. aeruginosa, as genes conferring resistance to both are often co-located on mobile genetic elements. P. aeruginosa‘s relationship with heavy metals also enables it to play a role in bioremediation, although its pathogenicity must be carefully managed in clinical settings.

Iron: Essential for pigments and enzymes involved in iron scavenging and bacterial metabolism.

Zinc: Critical for proteases and metallothioneins.

What is P. aeruginosa’s relationship to heavy metals?

Aspect	Details on Relationship with Pseudomonas aeruginosa
Heavy Metal Tolerance & Resistance	P. aeruginosa resists toxic metals like lead (Pb), mercury (Hg), copper (Cu), zinc (Zn), and cadmium (Cd) via efflux pumps (e.g., CzcCBA for cadmium, zinc, and cobalt), metal-binding proteins (metallothioneins), and enzymatic detoxification (e.g., mercuric reductase). These mechanisms help it survive in contaminated environments.
Biofilm Formation & Metal Resistance	Biofilms protect P. aeruginosa from heavy metal toxicity by trapping metal ions, reducing their penetration into bacterial cells. Biofilms also allow horizontal gene transfer of metal resistance genes, enhancing adaptability in metal-rich environments and increasing resistance to both heavy metals and antibiotics.
Iron Acquisition (Siderophores)	P. aeruginosa produces siderophores like pyoverdine and pyochelin to sequester iron, which is crucial for bacterial growth and virulence. Its ability to acquire iron in limited environments (e.g., human hosts) gives it a competitive edge during infections, especially in environments where iron is tightly regulated.
Magnesium & Calcium in Biofilm Stability	Magnesium (Mg) and calcium (Ca) are important for biofilm formation and stability, helping maintain biofilm matrix integrity and creating a protective environment for P. aeruginosa. This makes biofilm-associated infections more resistant to treatment and allows the bacterium to thrive in various environments.
Zinc-Dependent Enzymes & Virulence	Zinc (Zn) is essential for the activity of virulence factors like metalloproteases (e.g., LasB elastase) in P. aeruginosa. Zinc also contributes to biofilm formation, enhancing pathogenicity. High zinc levels can trigger the production of virulence factors such as pyocyanin, which induces oxidative stress in host cells.
Nickel as Co-factor (Glyoxalase I)	Nickel (Ni) serves as a co-factor for Glyoxalase I, an enzyme responsible for detoxifying methylglyoxal, a toxic metabolic byproduct. Nickel-dependent Glyoxalase I helps maintain cellular homeostasis under stress and may also play a role in potassium efflux, which supports osmotic balance and pH regulation, enhancing survival in diverse environments.
Heavy Metal-Induced Virulence	Sublethal concentrations of metals like zinc or copper can increase P. aeruginosa virulence by inducing the expression of toxins and proteases. For example, metals can stimulate the production of pyocyanin, a virulence factor that contributes to oxidative stress in the host and enhances the bacterium’s ability to cause damage.
Heavy Metals & Antibiotic Resistance	Heavy metal resistance and antibiotic resistance are closely linked in P. aeruginosa. Efflux pumps and biofilm formation confer resistance to both metals and antibiotics, and co-selection occurs because the genes for metal and antibiotic resistance are often located on the same mobile genetic elements (e.g., plasmids or transposons).

Enzyme/Virulence Factor	Function	Metal Cofactor	Notes
Phospholipase C (PlcH, PlcN)	Hydrolyzes phospholipids, disrupts host cell membranes	Zinc (Zn²⁺)	Causes membrane damage and tissue inflammation.
Rhamnolipids	Biosurfactants that disrupt host membranes, aid biofilm formation	None directly	Regulated by Iron (Fe³⁺) via quorum-sensing systems.
LasB protease (Elastase)	Degrades elastin, collagen, immune proteins; disrupts extracellular matrix	Zinc (Zn²⁺)	A zinc-dependent metalloprotease; major virulence factor.
LasA protease	Degrades elastin and immune proteins	Zinc (Zn²⁺)	Works synergistically with LasB protease.
Alkaline protease (AprA)	Degrades immune components like complement proteins	Zinc (Zn²⁺)	Interferes with immune defense.
Other metalloproteases	Degrade host proteins and extracellular matrix	Zinc (Zn²⁺)	Includes various zinc-dependent proteases.

Interventions

The main benefit of microbiome-targeted interventions (MBTIs) against Pseudomonas aeruginosa lies in their ability to provide precise, sustainable, and less disruptive treatments, particularly in the face of rising antibiotic resistance. These interventions can restore microbial balance, disrupt biofilms, and modulate the immune system without the widespread damage caused by conventional antibiotics. As P. aeruginosa appears in the microbiome signatures of more conditions, such as endometriosis, these microbiome-targeted therapies offer a promising alternative to manage infections and mitigate disease progression in a more holistic and targeted manner.

Drug Repurposing

Repurposed drugs present a promising solution for challenging P. aeruginosa infections amid rising antibiotic resistance. Clinical trials are essential to confirm their safety and efficacy, while the strategy expedites alternative treatments by utilizing known safety and pharmacology profiles. Repurposed drugs that have been clinically studied or found effective against Pseudomonas aeruginosa:

Non-pharmacological treatments

Non-pharmacological treatments and strategies can play a significant role in managing infections caused by Pseudomonas aeruginosa, particularly in preventing infection spread and supporting the body’s natural defense mechanisms. These approaches can be especially valuable in managing chronic infections, such as those seen in cystic fibrosis patients, or in settings where antibiotic resistance is a concern. Below is a table summarizing clinically studied non-pharmacological treatments found to be effective against Pseudomonas aeruginosa:

Intervention	Mechanism/Effectiveness Against Pseudomonas aeruginosa
Biofilm Disruption Techniques	Physical or chemical methods like ultrasonic waves or enzymatic treatments disrupt biofilms, helping to treat chronic P. aeruginosa infections, especially in biofilm-associated infections such as those in cystic fibrosis.
Photodynamic Therapy	Light-sensitive compounds generate reactive oxygen species when exposed to light, effectively killing P. aeruginosa and showing promise in treating antibiotic-resistant infections, particularly in resistant strains.
Bacteriophage Therapy	Utilizes bacteriophages that specifically target and kill P. aeruginosa, offering an alternative or adjunct treatment for antibiotic-resistant infections, particularly in wound care and respiratory infections.
EDTA Chelation	Chelates metal ions, disrupting the biofilm matrix of P. aeruginosa, increasing membrane permeability, and enhancing antimicrobial penetration, thereby reducing bacterial viability in biofilm-related infections.
Gallium Chelation	Acts as an iron mimic, disrupting iron metabolism in P. aeruginosa and reducing bacterial growth and biofilm formation. It has been shown to decrease P. aeruginosa lung infections and inflammation in cystic fibrosis models.

Supplements

Research into alternative and complementary treatments, including vitamins, supplements, essential oils, and flavonoids, has shown potential in combating Pseudomonas aeruginosa, particularly with respect to their antimicrobial and anti-biofilm activities. Below is a table summarizing some of these substances that have been clinically investigated or studied in laboratory settings for their effectiveness against P. aeruginosa.

Substance	Mechanism/Effectiveness Against Pseudomonas aeruginosa
Tea Tree Oil	Exhibits antimicrobial activity against P. aeruginosa, disrupts biofilms, and reduces bacterial load in wound infections.
Eucalyptus Oil	Broad-spectrum antimicrobial effects, including activity against P. aeruginosa. Used topically or in vapor form for wound and respiratory infections.
Quercetin	Inhibits biofilm formation and reduces P. aeruginosa virulence due to its antioxidant and anti-inflammatory properties.
Resveratrol	Antimicrobial effects against P. aeruginosa, inhibits biofilm formation, and reduces bacterial proliferation and virulence.
Garlic Extract (Allicin)	Damages bacterial cell walls and interferes with quorum sensing, which helps to reduce P. aeruginosa growth and virulence.
Curcumin	Disrupts biofilms and reduces P. aeruginosa virulence factors through antioxidant, anti-inflammatory, and antimicrobial activity.
Eugenol	Demonstrates antimicrobial and anti-biofilm activity, effectively disrupting P. aeruginosa biofilms and inhibiting bacterial growth.
Thymol	Strong antimicrobial properties effective against P. aeruginosa, especially in disrupting biofilms and reducing bacterial virulence.
Linalool	Exhibits antimicrobial and potential anti-biofilm activity, inhibiting P. aeruginosa growth in vitro.
Carvacrol	Displays antimicrobial and biofilm-inhibiting effects against P. aeruginosa, showing bactericidal activity in vitro.

References

1. Integrating respiratory microbiome and host immune response through machine learning for respiratory tract infection diagnosis. NPJ biofilms and microbiomes. Chen H, Qi T, Guo S, Zhang X, Zhan M, Liu S, Yin Y, Guo Y, Zhang Y, Zhao C, Wang X , Wang H (2024)
2. Metagenomic Profiling of Ocular Surface Microbiome Changes in Meibomian Gland Dysfunction. Investigative ophthalmology & visual science. Zhao F, Zhang D, Ge C, Zhang L, Reinach PS, Tian X, Tao C, Zhao Z, Zhao C, Fu W, Zeng C , Chen W (2020)
3. Mucosa-Associated Microbiota in Gastric Cancer Tissues Compared With Non-cancer Tissues. Frontiers in microbiology. Chen XH, Wang A, Chu AN, Gong YH , Yuan Y (2019)
4. Mucosa-Associated Microbiota in Gastric Cancer Tissues Compared With Non-cancer Tissues. Frontiers in microbiology. Chen XH, Wang A, Chu AN, Gong YH , Yuan Y (2019)
5. 16S rRNA gene sequencing reveals altered composition of gut microbiota in individuals with kidney stones. Urolithiasis. Tang R, Jiang Y, Tan A, Ye J, Xian X, Xie Y, Wang Q, Yao Z , Mo Z (2018)
6. Fecal Microbiota Taxonomic Shifts in Chinese Multiple Myeloma Patients Analyzed by Quantitative Polimerase Chain Reaction (QPCR) and 16S rRNA High-Throughput Sequencing. Medical science monitor : international medical journal of experimental and clinical research. Zhang B, Gu J, Liu J, Huang B , Li J (2019)
7. Evaluation of the Associations Between Cervical Microbiota and HPV Infection, Clearance, and Persistence in Cytologically Normal Women. Cancer prevention research (Philadelphia, Pa.). Ritu W, Enqi W, Zheng S, Wang J, Ling Y , Wang Y (2019)
8. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis. Digestive diseases and sciences. Shukla R, Ghoshal U, Dhole TN , Ghoshal UC (2015)
9. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis. Digestive diseases and sciences. Shukla R, Ghoshal U, Dhole TN , Ghoshal UC (2015)
10. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis. Digestive diseases and sciences. Shukla R, Ghoshal U, Dhole TN , Ghoshal UC (2015)
11. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis. Digestive diseases and sciences. Shukla R, Ghoshal U, Dhole TN , Ghoshal UC (2015)
12. Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients. Scientific reports. Corrêa JD, Fernandes GR, Calderaro DC, Mendonça SMS, Silva JM, Albiero ML, Cunha FQ, Xiao E, Ferreira GA, Teixeira AL, Mukherjee C, Leys EJ, Silva TA , Graves DT (2019)
13. Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients. Scientific reports. Corrêa JD, Fernandes GR, Calderaro DC, Mendonça SMS, Silva JM, Albiero ML, Cunha FQ, Xiao E, Ferreira GA, Teixeira AL, Mukherjee C, Leys EJ, Silva TA , Graves DT (2019)
14. Acute SARS-CoV-2 infection is associated with an expansion of bacteria pathogens in the nose including <i>Pseudomonas Aeruginosa</i>. bioRxiv : the preprint server for biology. Rhoades NS, Pinski A, Monsibais AN, Jankeel A, Doratt BM, Cinco IR, Ibraim I , Messaoudi I (2021)
15. Acute SARS-CoV-2 infection is associated with an expansion of bacteria pathogens in the nose including <i>Pseudomonas Aeruginosa</i>. bioRxiv : the preprint server for biology. Rhoades NS, Pinski A, Monsibais AN, Jankeel A, Doratt BM, Cinco IR, Ibraim I , Messaoudi I (2021)
16. Acute SARS-CoV-2 infection is associated with an expansion of bacteria pathogens in the nose including <i>Pseudomonas Aeruginosa</i>. bioRxiv : the preprint server for biology. Rhoades NS, Pinski A, Monsibais AN, Jankeel A, Doratt BM, Cinco IR, Ibraim I , Messaoudi I (2021)
17. Acute SARS-CoV-2 infection is associated with an expansion of bacteria pathogens in the nose including <i>Pseudomonas Aeruginosa</i>. bioRxiv : the preprint server for biology. Rhoades NS, Pinski A, Monsibais AN, Jankeel A, Doratt BM, Cinco IR, Ibraim I , Messaoudi I (2021)
18. The Influence of Age and Sex on Ocular Surface Microbiota in Healthy Adults. Investigative ophthalmology & visual science. Wen X, Miao L, Deng Y, Bible PW, Hu X, Zou Y, Liu Y, Guo S, Liang J, Chen T, Peng GH, Chen W, Liang L , Wei L (2017)
19. Geographic Difference Shaped Human Ocular Surface Metagenome of Young Han Chinese From Beijing, Wenzhou, and Guangzhou Cities. Investigative ophthalmology & visual science. Deng Y, Wen X, Hu X, Zou Y, Zhao C, Chen X, Miao L, Li X, Deng X, Bible PW, Ke H, Situ J, Guo S, Liang J, Chen T, Zou B, Liu Y, Chen W, Wu K, Zhang M, Jin ZB, Liang L , Wei L (2020)
20. Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease. Frontiers in cell and developmental biology. Liang Q, Li J, Zou Y, Hu X, Deng X, Zou B, Liu Y, Wei L, Liang L , Wen X (2021)
21. Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease. Frontiers in cell and developmental biology. Liang Q, Li J, Zou Y, Hu X, Deng X, Zou B, Liu Y, Wei L, Liang L , Wen X (2021)
22. Upper respiratory tract microbiome profiles in SARS-CoV-2 Delta and Omicron infected patients exhibit variant specific patterns and robust prediction of disease groups. Microbiology spectrum. Nath S, Sarkar M, Maddheshiya A, De D, Paul S, Dey S, Pal K, Roy SK, Ghosh A, Sengupta S, Paine SK, Biswas NK, Basu A , Mukherjee S (2023)
23. Upper respiratory tract microbiome profiles in SARS-CoV-2 Delta and Omicron infected patients exhibit variant specific patterns and robust prediction of disease groups. Microbiology spectrum. Nath S, Sarkar M, Maddheshiya A, De D, Paul S, Dey S, Pal K, Roy SK, Ghosh A, Sengupta S, Paine SK, Biswas NK, Basu A , Mukherjee S (2023)
24. The Interaction between Intratumoral Microbiome and Immunity Is Related to the Prognosis of Ovarian Cancer. Microbiology spectrum. Sheng D, Yue K, Li H, Zhao L, Zhao G, Jin C , Zhang L (2023)